Evidence map›Paper›PMID 26383724›Full record

ArticleJournal of the American College of Cardiology2015

A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.

Merry L Lindsey, Rugmani Padmanabhan Iyer, Rogelio Zamilpa, Andriy Yabluchanskiy, Kristine Y DeLeon-Pennell, Michael E Hall, Abdullah Kaplan, Fouad A Zouein, Dustin Bratton, Elizabeth R Flynn and 7 more

Abstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 3 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 3 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Guidelines for authors and reviewers on antibody use in physiology studies.American journal of physiology. Heart and circulatory physiology · 2018
    Guideline
  2. Guidelines for measuring cardiac physiology in mice.American journal of physiology. Heart and circulatory physiology · 2018
    Guideline
  3. Guidelines for experimental models of myocardial ischemia and infarction.American journal of physiology. Heart and circulatory physiology · 2018
    Guideline
  4. Decellularized cardiac ECM: A tissue-specific bioactive platform for drug release and cell delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  5. Optimized cardiac leukocyte isolation for flow cytometry enumeration and sorting.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Collagen type I degradation peptide as a predictive biomarker for mortality in ST-elevated myocardial infarction.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Guidelines on antibody use in physiology research.American journal of physiology. Renal physiology · 2024
    Article
  18. Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Merry L LindseyMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Research Service, G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, Mississippi.
Rugmani Padmanabhan IyerMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Rogelio ZamilpaSan Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Andriy YabluchanskiyMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Kristine Y DeLeon-PennellMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Michael E HallDivision of Cardiology and Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi.
Abdullah KaplanMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Fouad A ZoueinMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Dustin BrattonMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Elizabeth R FlynnMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Presley L CannonMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Yuan TianMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas.
Yu-Fang JinSan Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Department of Electrical and Computer Engineering, University of Texas at San Antonio, San Antonio, Texas.
Richard A LangeSan Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, Texas.
Dorota Tokmina-RoszykSan Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Florida Atlantic University, Department of Chemistry and Biochemistry, Jupiter, Florida.
Gregg B FieldsSan Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Florida Atlantic University, Department of Chemistry and Biochemistry, Jupiter, Florida.
Lisandra E de Castro BrásMississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; San Antonio Cardiovascular Proteomics Center, University of Texas Health Science Center, San Antonio, Texas; Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina. Electronic address: decastrobrasl14@ecu.edu.
The University of Texas Health Science Center at San Antonio · USTexas Tech University · USUniversity of Mississippi Medical Center · US

Funding

STRUCTURAL VASCULAR ADAPTATION OF THE MICROCIRCULATIONP01HL051971 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI ALEXANDER, BARBARA T · 1993 to 2018
$39.4M
The role of leptin in autoimmune-associated hypertensionP20GM104357 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI TAYLOR, ERIN BASSFORD · 2013 to 2022
$23.4M
The Role of Macrophage-derived MMPs in LV RemodelingR01HL075360 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LINDSEY, MERRY L. · 2004 to 2018
$5.4M
Mechanism &Inhibition of Collagenolytic ActivityR01CA098799 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FIELDS, GREGG B · 2003 to 2017
$4.5M
Neutrophil Polarization Following Myocardial InfarctionI01BX000505 · VA · VETERANS HEALTH ADMINISTRATION · PI LINDSEY, MERRY L. · 2009 to 2024
–
BLRD VA I01 BX000505NCI NIH HHS R01 CA098799NHLBI NIH HHS HHSN268201000036CNHLBI NIH HHS HL051971NHLBI NIH HHS HL075360NHLBI NIH HHS N01-HV-00244NHLBI NIH HHS P01 HL051971NHLBI NIH HHS R01 HL075360NIGMS NIH HHS GM104357NIGMS NIH HHS P20 GM104357PHS HHS HHSN268201000036C
6 · The paper itself

Abstract

backgroundProteolytically released extracellular matrix (ECM) fragments, matricryptins, are biologically active and play important roles in wound healing. Following myocardial infarction (MI), collagen I, a major component of cardiac ECM, is cleaved by matrix metalloproteinases (MMPs).

objectivesThis study identified novel collagen-derived matricryptins generated post-MI that mediate remodeling of the left ventricle (LV).

methodsRecombinant collagen Ia1 was used in MMPs cleavage assays, the products were analyzed by mass spectrometry for identification of cleavage sites. C57BL6/J mice were given MI and animals were treated either with vehicle control or p1158/59 matricryptin. Seven days post-MI, LV function and parameters of LV remodeling were measured. Levels of p1158/59 were also measured in plasma of MI patients and healthy controls.

resultsIn situ, MMP-2 and -9 generate a collagen Iα1 C-1158/59 fragment, and MMP-9 can further degrade it. The C-1158/59 fragment was identified post-MI, both in human plasma and mouse LV, at levels that inversely correlated to MMP-9 levels. We synthesized a peptide beginning at the cleavage site (p1158/59, amino acids 1159 to 1173) to investigate its biological functions. In vitro, p1158/59 stimulated fibroblast wound healing and robustly promoted angiogenesis. In vivo, early post-MI treatment with p1158/59 reduced LV dilation at day 7 post-MI by preserving LV structure (p < 0.05 vs. control). The p1158/59 stimulated both in vitro and in vivo wound healing by enhancing basement membrane proteins, granulation tissue components, and angiogenic factors.

conclusionsCollagen Iα1 matricryptin p1158/59 facilitates LV remodeling post-MI by regulating scar formation through targeted ECM generation and stimulation of angiogenesis.

Indexed as

Ventricular RemodelingAmino Acid SequenceAnimalsCicatrixCollagen Type ICollagen Type I, alpha 1 ChainDrug Evaluation, PreclinicalExtracellular MatrixFemaleHumansHuman Umbilical Vein Endothelial CellsMaleMatrix Metalloproteinase 9Mice, Inbred C57BLMiddle AgedMolecular Sequence DataCollagen Type ICollagen Type I, alpha 1 ChainMatrix Metalloproteinase 9p1158-59 peptide, humancollagenextracellular matrixmatricyrptinMMPproteomicsremodeling

Identifiers

PMID26383724
PMCPMC4575409
OpenAlexW1845851564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.